Background Multimorbidity and the associated use of multiple medicines (polypharmacy), is
common in the older population. Despite this, there is no consensus definition for …

A high rate of polypharmacy is, in part, a consequence of the increasing proportion of
multimorbidity in the ageing population worldwide. Our understanding of the potential harm …

Introduction: Polypharmacy, defined as the use of multiple drugs or more than are medically
necessary, is a growing concern for older adults. MEDLINE and EMBASE databases were …

Objective Polypharmacy has been linked to a myriad of adverse consequences, and
escalating rates of polypharmacy present an emerging concern, particularly among older …

Polypharmacy and heart failure are becoming increasingly common due to an ageing
population and the rise of multimorbidity. Treating heart failure necessitates prescribing of …

The older population, composed of adults aged 65 years or older, is the fastest growing
segment of the United States population. The Administration of Aging of the United States …

Background Poor adherence may have a major impact on clinical outcome, contributing to
substantial worsening of disease, increased health care costs and even death. With …

Background: Adverse drug reactions (ADRs) are an important public health problem,
representing a major cause of morbidity and mortality. However, several countries have no …

The pattern of patients admitted to internal medicine wards has dramatically changed in the
last 20–30 years. Elderly people are now the most rapidly growing proportion of the patient …

Purpose Polypharmacy—the use of multiple medications by a single patient—is an
important issue associated with various adverse clinical outcomes and rising costs. It is also …